美国乳房再造差异的缩小:基于3个全国数据库2005至2017年的分析
该研究利用3个全国数据库分析2005至2017年美国乳房切除术后乳房再造率的变化趋势及相关社会人口学因素。共纳入1,554,381例乳房切除术患者,其中507,631例(32.7%)接受乳房再造。乳房再造率在2005至2012年逐年上升,2013至2017年趋于稳定;黑种人和亚裔患者及医疗补助和医疗保险患者的乳房再造率增长幅度高于白种人和商业保险患者,基于种族和保险类型的差异有所缩小。
要点
- 2005至2012年乳房再造率逐年上升,2013至2017年趋于稳定。
- 年轻、商业保险、合并症少及对侧预防性乳房切除者更可能接受乳房再造(均P<0.001)。
- 黑种人、亚裔及医疗补助、医疗保险患者的乳房再造率增长幅度高于白种人和商业保险患者。
核心结论
- 过去十年即刻乳房再造率趋于稳定,原因可能是多方面的;基于种族和保险类型的差异有所缩小,乳房再造率分布更加公平。
研究设计与样本
- 从国家外科质量改进计划数据库、监测流行病学和最终结果计划数据库及国家癌症数据库提取2005至2017年乳房切除伴或不伴乳房再造的病例。
- 共纳入1,554,381例乳房切除术患者,其中507,631例(32.7%)接受乳房再造。
- 采用泊松回归分析乳房再造率,并对国家癌症数据库数据进行多因素logistic回归分析以识别再造的预测因素。
主要发现
- 每1000例乳房切除术的年度再造率从2005至2012年上升:国家外科质量改进计划发生率比(IRR)1.077,监测流行病学和最终结果计划IRR 1.090,国家癌症数据库IRR 1.092;2013至2017年趋于稳定。
- 国家癌症数据库数据显示,年龄≤59岁、商业保险、合并症较少及接受对侧预防性乳房切除术的患者更可能接受乳房再造(均P<0.001)。
- 随时间推移,黑种人(252.3%)和亚裔(366.4%)患者的乳房再造率增长高于白种人(137.3%)。
- 医疗补助(418.6%)和医疗保险(302.8%)患者的乳房再造率增长高于商业保险患者(125.3%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following passage of the Women's Health and Cancer Rights Act of 1998 (WHCRA), a steady rise in breast reconstruction rates was reported; however, a recent update is lacking. This study aimed to evaluate longitudinal trends in breast reconstruction (BR) rates in the United States and relevant sociodemographic factors. METHODS: Mastectomy cases with and without BR from 2005 through 2017 were abstracted from the National Surgical Quality Improvement Program database; the Surveillance, Epidemiology, and End Results Program database; and the National Cancer Database (NCDB). BR rates were examined using Poisson regression. Multivariable logistic regression analysis of NCDB data were used to identify predictors of reconstruction. Race and insurance distributions were evaluated over time. RESULTS: Of 1,554,381 mastectomy patients, 507,631 (32.7%) underwent BR. Annual reconstruction rates per 1000 mastectomies increased from 2005 to 2012 (National Surgical Quality Improvement Program incidence rate ratio [IRR], 1.077; Surveillance, Epidemiology, and End Results Program IRR, 1.090; and NCDB IRR, 1.092) and stabilized from 2013 to 2017. NCDB data showed that patients who were younger (≤59 years), privately insured, had fewer comorbidities, and underwent contralateral prophylactic mastectomy were more likely to undergo BR (all P < 0.001). Over time, the increase in BR rates was higher among Black (252.3%) and Asian (366.4%) patients than among White patients (137.3%). BR rates increased more among Medicaid (418.6%) and Medicare (302.8%) patients than among privately insured patients (125.3%). CONCLUSIONS: This analysis demonstrates stabilization in immediate BR rates over the past decade; reasons behind this stabilization are likely multifactorial. Disparities based on race and insurance type have decreased, with a more equitable distribution of BR rates. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Rubenstein RN, Nelson JA, Azoury SC, et al. Disparity Reduction in U.S. Breast Reconstruction: An Analysis from 2005 to 2017 Using 3 Nationwide Data Sets. Plast Reconstr Surg. 2024. PMID: 38546540. doi:10.1097/PRS.0000000000011432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。